Evidence map›Paper›PMID 33841418›Full record

ArticleFrontiers in immunology2021

Proteomic Characterization, Biodistribution, and Functional Studies of Immune-Therapeutic Exosomes: Implications for Inflammatory Lung Diseases.

Mahmoud Elashiry, Ranya Elsayed, Mohamed M Elashiry, Mohammad H Rashid, Roxan Ara, Ali S Arbab, Ahmed R Elawady, Mark Hamrick, Yutao Liu, Wenbo Zhi and 3 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Role of dendritic cell‑derived exosomes in allergic rhinitis (Review).International journal of molecular medicine · 2023
    Review
  8. Article
  9. Review
  10. Review
  11. Frontiers in pharmacology · 2022
    Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Review
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 2 countries.

Mahmoud ElashiryDepartment of Periodontics, Dental College of Georgia at Augusta University, Augusta, GA, United States.
Ranya ElsayedDepartment of Periodontics, Dental College of Georgia at Augusta University, Augusta, GA, United States.
Mohamed M ElashiryDepartment of Periodontics, Dental College of Georgia at Augusta University, Augusta, GA, United States.
Mohammad H RashidGeorgia Cancer Center, Department of Biochemistry and Molecular Biology, at Augusta University, Augusta, GA, United States.
Roxan AraGeorgia Cancer Center, Department of Biochemistry and Molecular Biology, at Augusta University, Augusta, GA, United States.
Ali S ArbabGeorgia Cancer Center, Department of Biochemistry and Molecular Biology, at Augusta University, Augusta, GA, United States.
Ahmed R ElawadyDepartment of Periodontics, Dental College of Georgia at Augusta University, Augusta, GA, United States.
Mark HamrickDepartment of Cellular Biology and Anatomy, Medical College of Georgia at Augusta University, Augusta, GA, United States.
Yutao LiuDepartment of Cellular Biology and Anatomy, Medical College of Georgia at Augusta University, Augusta, GA, United States.
Wenbo ZhiCenter of Biotechnology and Genomic Medicine, at Augusta University, Augusta, GA, United States.
Rudolf LucasVascular Biology Center, Medical College of Georgia at Augusta University, Augusta, GA, United States.
Jose VazquezDivision of Infectious Diseases, Department of Medicine, Medical College of Georgia at Augusta University, Augusta, GA, United States.
Christopher W CutlerDepartment of Periodontics, Dental College of Georgia at Augusta University, Augusta, GA, United States.
Augusta University · USAugusta University Health · US

Funding

ENaC-α mediates lung fluid clearance and capillary barrier function in pneumoniaR01HL138410 · NHLBI · AUGUSTA UNIVERSITY · PI LUCAS, RUDOLF · 2018 to 2021
$2.0M
NHLBI NIH HHS R01 HL138410
6 · The paper itself

Abstract

Dendritic cell (DC)-derived exosomes (DC EXO), natural nanoparticles of endosomal origin, are under intense scrutiny in clinical trials for various inflammatory diseases. DC EXO are eobiotic, meaning they are well-tolerated by the host; moreover, they can be custom-tailored for immune-regulatory or -stimulatory functions, thus presenting attractive opportunities for immune therapy. Previously we documented the efficacy of immunoregulatory DCs EXO (regDCs EXO) as immunotherapy for inflammatory bone disease, in an

Indexed as

AnimalsCOVID-19Dendritic CellsExosomesMiceProteomeProteomicsReceptor, Transforming Growth Factor-beta Type ISARS-CoV-2Transforming Growth Factor beta1ProteomeReceptor, Transforming Growth Factor-beta Type ITgfb1 protein, mouseTgfbr1 protein, mouseTransforming Growth Factor beta1COVID-19dendritic cellsexosomesimmune therapylung diseases

Identifiers

PMID33841418
PMCPMC8027247
OpenAlexW3149475855

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.